'Your papers, please' must never be heard in America
Independent voices from the TWT Communities
Young cancer patients who couldn't get a key medicine because of a national drug shortage were more likely to suffer a relapse than others who were able to get the preferred treatment, doctors report. It's the first evidence that a long-standing drug-supply problem probably has affected cancer treatment results in specific patients.
"We really couldn't put our finger on, did anybody really suffer?" said Dr. Michael Link, a cancer specialist at Stanford University and past president of the American Society of Clinical Oncology.
